| Literature DB >> 29881810 |
Jesús-Servando Medel-Matus1, Don Shin1, Edward Dorfman1, Raman Sankar1,2,3, Andrey Mazarati1,3.
Abstract
There has been growing interest in the role of intestinal microbiome in brain disorders. We examined whether dysbiosis can predispose to epilepsy. The study was performed in female and male Sprague-Dawley rats. To induce dysbiosis, the rats were subjected to chronic restraint stress (two 2-h long sessions per day, over 2 weeks). Cecal content from stressed and sham-stressed donors was transplanted via oral gavage to recipients, in which commensal microbiota had been depleted by the antibiotics. The study included the following groups: (1) Sham stress, no microbiota transplant; (2) Stress, no microbiota transplant; (3) Sham-stressed recipients transplanted with microbiota from sham-stressed donors; (4) Stressed recipients transplanted with microbiota from sham-stressed donors; (5) Sham-stressed recipients transplanted with microbiota from stressed donors; and (6) Stressed recipients transplanted with microbiota from stressed donors. After microbiota transplant, all animals were subjected to kindling of the basolateral amygdala. Both chronic stress and microbiome transplanted from stressed to sham-stressed subjects accelerated the progression and prolonged the duration of kindled seizures. Microbiome from sham-stressed animals transplanted to chronically stressed rats, counteracted proepileptic effects of restraint stress. These findings directly implicate perturbations in the gut microbiome, particularly those associated with chronic stress, in the increased susceptibility to epilepsy.Entities:
Keywords: Brain; Dysbiosis; Epilepsy; Microbiota
Year: 2018 PMID: 29881810 PMCID: PMC5983141 DOI: 10.1002/epi4.12114
Source DB: PubMed Journal: Epilepsia Open ISSN: 2470-9239
Figure 1Experimental design and baseline afterdischarge properties. (A) Directions of microbiome transplants by types of donors and recipients. (B) Baseline afterdischarge properties. D, microbiota donors; R, microbiota recipients. Afterdischarge threshold (ADT). Stress‐microbiome interaction F(2, 30) = 0.3, p > 0.1; effects of stress F(1, 30) = 0.3, p > 0.1; effects of microbiome F(2, 30) = 1.4, p > 0.1. Afterdischarge duration (ADD). Stress microbiome interaction F(2, 30) = 0.05, p > 0.1. Effects of stress F(1, 30) = 10.2, p < 0.01; effects of microbiome F(2, 30) = 0.3, p > 0.1. No intergroup differences were observed. Data are shown as mean ± SD percent vs mean of controls (actual numbers were used for statistical analysis). 2‐way ANOVA, post hoc Tukey.
Figure 2Effects of stress and of intestinal microbiota transplants kindling. (A) Kindling progression. D, microbiota donors; R, microbiota recipients. Shown are individual data (scatter) with median ± range. 2‐way ANOVA, post hoc Tukey. **p < 0.01; ***p < 0.001 vs Control; Power a‐b 95%, a‐e, and a‐f 99%. ††p < 0.01; †††p < 0.001 vs Stress. Power b‐c and b‐d 99%. Stress‐microbiome interaction F(2, 30) = 6.0, p < 0.01. Effects of stress F(1, 30) = 4.2, p < 0.05; effects of microbiome F(2, 30) = 24.5, p < 0.0001. (B) Duration of electrographic seizure at the end of kindling, induced by test stimulation. Shown are individual data (scatter) with mean ± SD. Female rats are indicated by circles. 2‐way ANOVA, post hoc Tukey. *p < 0.05, *p < 0.05, **p < 0.01 vs Control. Power a‐b 95%, a‐e 70%, a‐f 95%. †p < 0.05; †††p < 0.001 vs. Stress. Power b‐c 99%, b‐d 85%. Stress‐microbiome interaction F(2, 30) = 2.4 p > 0.1. Effects of stress F(1, 30) = 12.4, p < 0.01; effects of microbiome F(2, 30) = 16.2, p < 0.0001.